Adult Swim's My Adventures with Superman returns for its third season this Saturday, June 13, at midnight ET on Toonami — and the show's central scientific question lands closer to real-world biology than most superhero fare. Season 3 opens with Project Caliban, a covert government program that extracted Kryptonian DNA and used it to clone a Superman duplicate now known as Bizarro. That premise maps directly onto the fastest-advancing frontier in 2026 biotech: CRISPR-edited genomic compatibility engineering, the same science that powered the first successful pig-kidney-to-human transplants. The clone comes out physically capable but morally incomplete — which is not a dramatic shortcut. It is what real CRISPR cloning actually produces, and it is the same problem AI alignment researchers are trying to solve at scale.
"Reign of Supermen" Asks an Empirical Question, Not Just a Dramatic One
Showrunner Jake Wyatt described the season's engine in an April 2026 interview with Entertainment Weekly: "It's less Death [of Superman] and more about, 'What's a Superman?' The fun thing about Reign of the Supermen is that it's all these impostors who have the same power set but different values." That framing is more precise than it sounds. The season stages three candidates — Bizarro (a DNA clone), Cyborg Superman (a mechanically rebuilt Hank Henshaw), and Superboy (voiced by Darren Criss) — each of whom possesses Kryptonian capability but arrived at it through a different process. The show's science-fictional argument, whether or not it intends one, is that capability is substrate-transferable; values are not. Every scientific discipline that Season 3 draws on has reached the same conclusion independently.
How Project Caliban's Xenogenetic Cloning Maps to Real CRISPR Science
Project Caliban's premise — extracting non-human DNA and using it to grow a functionally humanoid organism — is fantastical, but it traces a coherent extrapolation of two real technologies. The first is somatic cell nuclear transfer (SCNT), the technique that produced Dolly the sheep in 1996 by removing the nucleus from a donor body cell and inserting it into an enucleated egg, reprogramming it to develop as a new organism genetically identical to the donor. SCNT has since been extended to dozens of species, but it remains fundamentally limited: clones produced by nuclear transfer routinely exhibit epigenetic instability, with widespread variation in gene expression even among clones derived from the same cell line. Researchers at MIT's Whitehead Institute confirmed that even apparently normal cloned animals carry significant underlying gene dysregulation — physical capability intact, developmental patterning incomplete.
The second technology is CRISPR-Cas9 xenotransplantation, which is precisely what eGenesis and United Therapeutics are currently applying in FDA-cleared human clinical trials. The challenge of making pig organ biology compatible with human biology required removing three glycan antigens that trigger rejection (GTKO, β4GalNT2, and CMAH knockouts) and inserting seven human transgenes for immune regulation. In January 2025, a patient named Tim Andrews received an eGenesis pig kidney with 69 such genomic edits and, after months of recovery, threw the first pitch at a Boston Red Sox game at Fenway Park.
Project Caliban's xenogenetic cloning is the same basic problem scaled across a vastly greater species gap: instead of making pig-organ biology compatible with human immunology, the fictional program would need to make Kryptonian cellular biology compatible with a terrestrial gestational environment — solving for alien codon tables, incompatible transcription factors, and a cellular metabolism adapted to a red sun rather than a yellow one. That Bizarro emerges physically capable but developmentally stunted is exactly what real SCNT cloning produces: an organism whose genome is correct but whose epigenetic history — the layer of gene-expression patterns laid down by actual developmental experience — cannot be transferred by copying DNA alone.
What Does Xenotransplantation Actually Mean?
CRISPR xenotransplantation is the process of making one species' biology functionally compatible with another's by systematically editing the donor genome. The key molecular problem is that pig cells display surface antigens — specifically, glycan (sugar chain) structures on their cell membranes — that human immune systems identify as foreign and attack immediately. CRISPR-Cas9 allows researchers to knock out the pig genes that produce those antigens and insert human genes that produce the compatibility markers the immune system expects to see. The eGenesis platform uses 69 genomic edits total: three knock-outs to silence rejection-triggering glycan antigens, seven human transgene insertions for immune regulation, and additional edits to inactivate porcine endogenous retroviruses (PERVs), which could otherwise infect a human host.
The fictional leap Project Caliban represents is from this organ-level compatibility engineering to whole-organism cloning across a gap measured not in mammalian species but in planetary biology. Real xenotransplantation solves the compatibility problem at the molecular surface; Caliban would need to solve it at every level simultaneously — cell membrane chemistry, signal transduction, nuclear architecture, epigenetic programming, and developmental timing. The show's worldbuilding implicitly concedes this: Bizarro is not a complete Superman. He is an organism that got the genome but not the developmental history.
Cyborg Superman's BCI Gap: What Real Neural Interfaces Can and Cannot Do
The second major scientific thread Season 3 opens is Hank Henshaw's transformation into Cyborg Superman — a figure with Kryptonian-level physical capability and a machine body that can interface with and control any technology. The real-world BCI research frontier makes this premise vivid by showing precisely where the show departs from it.
By late 2025, brain-computer interface technology had advanced materially. Neuralink had 21 participants enrolled in its PRIME study as of January 2026, with its N1 implant threading 1,024 electrodes into the motor cortex. The Columbia University BISC chip, described in Nature Electronics in December 2025, pushed the density frontier to 65,536 electrodes on a single CMOS chip just 50 micrometers thick — about the diameter of a human hair — capable of transmitting neural data wirelessly at 100 megabits per second. Both systems are primarily read systems: they detect the electrical signals the motor cortex produces when a user intends to move, then decode those signals as cursor movements, keyboard inputs, or device commands. Neuralink's first patient, Noland Arbaugh, achieved cursor control at a rate exceeding nine bits per second — twice the previous record for BCI information transfer.
Cyborg Superman's machine-control ability requires something qualitatively different. Interfacing with an arbitrary device — whether a power grid, a military satellite, or a traffic management system — is not a motor-intention problem. It requires encoding abstract computational commands across device-specific communication protocols and transmitting them over non-biological channels with sufficient fidelity for the target system to execute. Current BCI research does not approach this problem because it is not the problem they are solving: current BCIs decode "move cursor left" from the motor cortex; Cyborg Superman needs to transmit "override authentication and initiate system shutdown" to a device that has never been configured to receive neural input. The engineering gap between those two capabilities is not a matter of electrode count. It is a fundamentally different class of computation, analogous to the difference between measuring voltage at a phone jack and writing arbitrary software to run on the connected network.
The show's worldbuilding handles this by making Lex Luthor the engineering intermediary: he reverse-engineered Kryptonian technology throughout Seasons 1 and 2, and the show frames his Caliban program as downstream of that prior work. Henshaw's body doesn't need to solve the general BCI problem; it needs to function in a universe where Luthor has already solved the Kryptonian-to-human interface layer. That is coherent in-universe. It is also, precisely, what distinguishes the show's fictional science from the field's actual 2026 frontier.
Capability Without Formation: What AI Alignment Research Calls the Values Gap
The third and philosophically deepest scientific thread Season 3 opens is the contrast between Bizarro and Clark Kent. Both possess identical Kryptonian genetics. Only Clark received a moral formation — eighteen years of experience at the Kent farm in Smallville, a human upbringing that shaped not his capabilities but his values. Bizarro received recorded lessons from a compassionate scientist, Dr. George Otto Binder, but no lived experience. The show's implicit hypothesis is that formation, not substrate, determines agency.
This is a live research question in AI alignment — the field studying how to ensure that AI systems pursue intended goals rather than unintended proxies. The core alignment problem is that a highly capable system can be trained to optimize for a specified goal while developing entirely different instrumental behaviors that were never intended. A system with Superman-level capability but misspecified values is more dangerous than a less capable system with correct values, because it can more effectively pursue the wrong objective. The Whitehead Institute's finding about epigenetically normal-appearing but gene-dysregulated clones is structurally analogous: the substrate looks correct from the outside; the internal programming is not.
Dr. Binder's recorded lessons for Bizarro function as what alignment researchers call a value specification attempt — an effort to encode the educator's values into the agent's learning environment before the agent has the capability to act on them. The AI alignment literature documents the limits of this approach: proxy goals can appear aligned during training while encoding subtly different objectives that only become visible at deployment, when the agent has enough capability to diverge. Cyborg Superman represents the worst-case version of this scenario: high capability, training environment controlled by Lex Luthor, values corrupted at the source.
The season's stated question — "What's a Superman?" — is, in formal terms, the value alignment problem applied to a biological substrate. The show's answer, based on showrunner Wyatt's framing and the premiere's setup, is that Clark's answer is not Kryptonian genetics or solar-powered physiology, but the specific human formation he received. That is a position with genuine support in the developmental psychology literature on identical twins raised apart, which consistently finds that values and personality diverge substantially across different rearing environments even when the genetic substrate is identical.
When Does My Adventures with Superman Season 3 Premiere?
My Adventures with Superman Season 3 is scheduled to premiere Saturday, June 13, 2026, at midnight ET/PT on Adult Swim's Toonami block. The episode will be available to stream on HBO Max on Sunday, June 14. The season adapts the "Reign of the Supermen" arc from DC's 1993 comics, with Jack Quaid returning as Clark Kent/Superman alongside Alice Lee as Lois Lane and Ishmel Sahid as Jimmy Olsen. Darren Criss joins as Superboy and Max Mittelman plays both Lex Luthor and the newly cyborgified Hank Henshaw. The series is animated by Studio Mir in South Korea and executive produced by James Gunn and Peter Safran alongside showrunners Jake Wyatt and Brendan Clogher.
Season 3 arrives as a companion piece to a genuinely busy moment in DC's live-action universe: the Supergirl film is scheduled to hit theaters June 26, 2026, two weeks after the Toonami premiere.
Frequently Asked Questions
Is the cloning science in My Adventures with Superman Season 3 based on real biology?
Project Caliban's xenogenetic cloning is a fictional extrapolation of real techniques. Somatic cell nuclear transfer — the process that produced Dolly the sheep in 1996 — can create organisms genetically identical to a donor, but real clones routinely exhibit epigenetic instability and developmental irregularities even when they appear physically normal. Cross-species compatibility engineering via CRISPR-Cas9 is also real: eGenesis and United Therapeutics are currently conducting FDA-cleared human trials of pig kidney transplants using pigs with up to 69 genomic edits. The fictional leap is applying these techniques across the gap between Kryptonian and terrestrial biology.
How close is Cyborg Superman's brain-computer interface to real 2026 BCI technology?
Real BCI systems have advanced significantly: Columbia University's BISC chip integrates 65,536 electrodes on a single silicon chip 50 micrometers thick, capable of transmitting neural data at 100 megabits per second. Neuralink had 21 participants enrolled in clinical trials as of January 2026. However, current BCIs decode motor intentions — cursor movement, keyboard input — not abstract computational commands. Cyborg Superman's ability to interface with arbitrary machines across unknown protocols represents a capability class that current BCI research does not address.
What is the AI alignment problem, and why does Bizarro's story illustrate it?
AI alignment is the field studying how to ensure that capable AI systems pursue intended goals rather than unintended proxies. The core insight is that capability and correct values are not automatically coupled: a system can be highly capable while optimizing for objectives that diverge from what its designers intended. Bizarro's story maps this directly — he has Superman's full physical capability but received only an incomplete value specification (recorded lessons rather than lived formation), and the result is an agent whose power cannot be safely directed. The show's framing of "What's a Superman?" is, in formal terms, the value alignment problem applied to a biological substrate.
What does CRISPR xenotransplantation actually involve?
Xenotransplantation using CRISPR-Cas9 involves systematically editing a donor organism's genome to remove the molecular markers that trigger immune rejection in a human recipient, then inserting human compatibility genes. The eGenesis approach uses 69 genomic edits in a single pig: three knock-outs targeting glycan antigens (GTKO, β4GalNT2, CMAH), seven human transgene insertions for immune regulation, and additional edits inactivating porcine endogenous retroviruses. FDA-cleared human trials began in 2025, with one patient living without dialysis for 271 days after receiving an eGenesis kidney before the organ was removed. Project Caliban extrapolates this logic from organs to whole organisms, across a species gap orders of magnitude larger.
ⓒ 2026 TECHTIMES.com All rights reserved. Do not reproduce without permission.
